ARRAY BIOPHARMA INC - NOTE 2.625%12/0

CUSIP: 04269XAB1

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / NOTE 2.625%12/0
Market price (% of par)
304.21%
Total 13F principal
$77,244,000
Principal change
-$41,038,000
Total reported market value
$237,676,000
Number of holders
11
Value change
-$69,578,693
Number of buys
6
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 04269XAB1?
CUSIP 04269XAB1 identifies 04269XAB1 - ARRAY BIOPHARMA INC - NOTE 2.625%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARRAY BIOPHARMA INC - NOTE 2.625%12/0 as of Q2 2019

As of 30 Jun 2019, ARRAY BIOPHARMA INC - NOTE 2.625%12/0 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $77,244,000 in principal (par value) of the bond. The largest 10 bondholders included CSS LLC/IL, Redmile Group, LLC, LAZARD ASSET MANAGEMENT LLC, Weiss Asset Management LP, CAPSTONE INVESTMENT ADVISORS, LLC, FMR LLC, DEUTSCHE BANK AG\, CITADEL ADVISORS LLC, AMERIPRISE FINANCIAL INC, and Jefferies Group LLC. This page lists 11 institutional bondholders reporting positions for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.